Zobrazeno 1 - 10
of 168
pro vyhledávání: '"Richard Viebahn"'
Autor:
Moritz Anft, Fabian Meyer, Sirin Czygan, Felix S. Seibert, Benjamin J. Rohn, Fotios Tsimas, Richard Viebahn, Timm H. Westhoff, Ulrik Stervbo, Nina Babel, Panagiota Zgoura
Publikováno v:
Frontiers in Transplantation, Vol 3 (2024)
In a previous study, we showed an anti-inflammatory effect of propionic acid supplementation in dialysis patients. The present study intends to analyze the effect of propionic acid on the chronic inflammatory state and T-cell composition in kidney tr
Externí odkaz:
https://doaj.org/article/ee66ffed8b1e4cf5a4244fed4df96a85
Autor:
Jana F. Karthäuser, Dierk Gruhn, Alejandro Martínez Guajardo, Regina Kopecz, Nina Babel, Ulrik Stervbo, André Laschewsky, Richard Viebahn, Jochen Salber, Axel Rosenhahn
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 12 (2024)
The fouling resistance of zwitterionic coatings is conventionally explained by the strong hydrophilicity of such polymers. Here, the in vitro biocompatibility of a set of systematically varied amphiphilic, zwitterionic copolymers is investigated. Pho
Externí odkaz:
https://doaj.org/article/0418445fdbba4cc8b21e037b910fd105
Autor:
Kamil S. Rosiewicz, Arturo Blazquez-Navarro, Sviatlana Kaliszczyk, Chris Bauer, Michal Or-Guil, Richard Viebahn, Panagiota Zgoura, Petra Reinke, Toralf Roch, Christian Hugo, Timm Westhoff, Constantin Thieme, Ulrik Stervbo, Nina Babel
Publikováno v:
Frontiers in Transplantation, Vol 3 (2024)
BackgroundMono and combined reactivation of latent viruses occurs frequently under immunosuppressive therapy in kidney transplant patients. Recently, monitoring torque teno virus (TTV) reactivation came more into focus as a potential biomarker for im
Externí odkaz:
https://doaj.org/article/5c3a10d975244e7db8c82ebdf3553391
Autor:
Timm M. Reissig, Swetlana Ladigan‐Badura, Anja Steinberg, Abdelouahid Maghnouj, Ting Li, Berlinda Verdoodt, Sven T. Liffers, Michael Pohl, Heiner Wolters, Christian Teschendorf, Richard Viebahn, Jakob Admard, Nicolas Casadei, Andrea Tannapfel, Wolff Schmiegel, Stephan A. Hahn, Deepak B. Vangala
Publikováno v:
Molecular Oncology, Vol 17, Iss 11, Pp 2396-2414 (2023)
Although approximately half of all metastatic colorectal cancers (mCRCs) harbour mutations in KRAS or NRAS, hardly any progress has been made regarding targeted treatment for this group over the last few years. Here, we investigated the efficacy of v
Externí odkaz:
https://doaj.org/article/43b89c56d838488bb188749e4ab6758c
Autor:
Irina Heid, Corinna Münch, Sinan Karakaya, Smiths S. Lueong, Alina M. Winkelkotte, Sven T. Liffers, Laura Godfrey, Phyllis F. Y. Cheung, Konstantinos Savvatakis, Geoffrey J. Topping, Florian Englert, Lukas Kritzner, Martin Grashei, Andrea Tannapfel, Richard Viebahn, Heiner Wolters, Waldemar Uhl, Deepak Vangala, Esther M. M. Smeets, Erik H. J. G. Aarntzen, Daniel Rauh, Wilko Weichert, Jörg D. Hoheisel, Stephan A. Hahn, Franz Schilling, Rickmer Braren, Marija Trajkovic-Arsic, Jens T. Siveke
Publikováno v:
Cancer & Metabolism, Vol 10, Iss 1, Pp 1-14 (2022)
Abstract Background Pancreatic ductal adenocarcinoma (PDAC) lacks effective treatment options beyond chemotherapy. Although molecular subtypes such as classical and QM (quasi-mesenchymal)/basal-like with transcriptome-based distinct signatures have b
Externí odkaz:
https://doaj.org/article/bde08f1443834615a3f9cb25e23e0e2b
Autor:
Arturo Blazquez-Navarro, Toralf Roch, Patrizia Wehler, Sviatlana Kaliszczyk, Chris Bauer, Constantin Thieme, Kamil S. Rosiewicz, Ulrik Stervbo, Moritz Anft, Petra Reinke, Christian Hugo, Panagiota Zgoura, Richard Viebahn, Timm Westhoff, Michal Or-Guil, Nina Babel
Publikováno v:
Frontiers in Transplantation, Vol 2 (2023)
Human herpesvirus 6 (HHV-6) is a common opportunistic pathogen in kidney transplant recipients. Two distinct species of HHV-6, HHV-6A and HHV-6B, have been identified, of which the latter seems to be dominant. However, it is unclear whether they incr
Externí odkaz:
https://doaj.org/article/d2d2b0ca01fe434295c2bb2f50f0036a
Autor:
Deepak Vangala, Swetlana Ladigan, Sven T. Liffers, Soha Noseir, Abdelouahid Maghnouj, Tina-Maria Götze, Berlinda Verdoodt, Susanne Klein-Scory, Laura Godfrey, Martina K. Zowada, Mario Huerta, Daniel L. Edelstein, Jaime Martinez de Villarreal, Miriam Marqués, Jörg Kumbrink, Andreas Jung, Tobias Schiergens, Jens Werner, Volker Heinemann, Sebastian Stintzing, Doris Lindoerfer, Ulrich Mansmann, Michael Pohl, Christian Teschendorf, Christiane Bernhardt, Heiner Wolters, Josef Stern, Selami Usta, Richard Viebahn, Jacob Admard, Nicolas Casadei, Stefan Fröhling, Claudia R. Ball, Jens T. Siveke, Hanno Glimm, Andrea Tannapfel, Wolff Schmiegel, Stephan A. Hahn
Publikováno v:
Genome Medicine, Vol 13, Iss 1, Pp 1-25 (2021)
Abstract Background The development of secondary resistance (SR) in metastatic colorectal cancer (mCRC) treated with anti-epidermal growth factor receptor (anti-EGFR) antibodies is not fully understood at the molecular level. Here we tested in vivo s
Externí odkaz:
https://doaj.org/article/cfb1d471a175414a977bd791dd7bb74a
Autor:
Nora Jahn, Ulrich Sack, Sebastian Stehr, Maria Theresa Vöelker, Sven Laudi, Daniel Seehofer, Selim Atay, Panagiota Zgoura, Richard Viebahn, Andreas Boldt, Hans-Michael Hau
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 20, p 6148 (2022)
Background: Despite recent advances and refinements in perioperative management of kidney transplantation (KT), early renal graft injury (eRGI) remains a critical problem with serious impairment of graft function as well as short- and long-term outco
Externí odkaz:
https://doaj.org/article/bd81a86eb99b477a918d23c76079c35e
Autor:
Tim Rahmel, Hartmuth Nowak, Sandra Frisenda, Katharina Rump, Björn Koos, Peter Schenker, Richard Viebahn, Michael Adamzik, Lars Bergmann
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Externí odkaz:
https://doaj.org/article/495beccbfaee42439506d4733add2a13
Autor:
Sandra Pacharra, Seán McMahon, Patrick Duffy, Pooja Basnett, Wenfa Yu, Sabine Seisel, Ulrik Stervbo, Nina Babel, Ipsita Roy, Richard Viebahn, Wenxin Wang, Jochen Salber
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 8 (2020)
Although the use of bioresorbable materials in stent production is thought to improve long-term safety compared to their durable counterparts, a recent FDA report on the 2-year follow-up of the first FDA-approved bioresorbable vascular stent showed a
Externí odkaz:
https://doaj.org/article/59cebf76103c493daa0f2a5d4c669914